Amol Choulwar
Group Leader- Regulatory Affairs (New DRUGS, Biosimilars, Peptides, Vaccines, Antibody-Drug Conjugate ) for India and Global Market
- Role
- Group Leader- Regulatory Affairs (Biosimilar Peptides New Drugs Vaccines) at Cipla
- Location
- Mumbai, MH, IN
- LinkedIn followers
- 500 followers
About Amol Choulwar
A well-qualified result oriented regulatory affairs professional with more than 17 years…
Experience
Group Leader- Regulatory Affairs (Biosimilar Peptides New Drugs Vaccines)
Jan 2023 — Present · Mumbai, IN
Responsible and accountable for Global CMC Regulatory Affairs (India, USA, Australia and Emerging market) and Regulatory Strategy/Inteligence during new product development.Product Range-New drugs, Biologics (Biosimilar, Vaccines, CAR- T gene therapy), Complex generics (Peptides, oligonucleotides), Novel Fixed dose combination (FDCs).
Education
SVKM's Narsee Monjee Institute of Management Studies (NMIMS)
Doctor of Philosophy (Ph.D.), Pharmaceutical Sciences
2008 — 2013
JSS College of Pharmacy, Ooty
M.Pharm, Pharmacy
2004 — 2006
Y.B.Chavan College of pharmacy, Aurangabad
B.Pharmacy
1999 — 2004
Skills
- Regulatory Submissions for India, Row and Emerging Market
- Microsoft Excel
- Powerpoint
- Microsoft Office
- Strategic Planning
- English
- Ctd
- Regulatory Affairs
- Research
- Ectd
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.